Lowell Therapeutics
Lowell, US · Founded 2018 · Delaware corporation
Founders & leadership
JW
JAMES WILKIENamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5M disclosed across 3 rounds · 2020–2021
▶$1MraisedNov 2021 · 21 investors · BiotechnologyRule 506(b)
▶$1MraisedNov 2021 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES WILKIEExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$203.1KraisedOct 2021 · 15 investors · BiotechnologyRule 506(b)
▶$203.1KraisedOct 2021 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES WILKIEExecutive Officer, Director
- Offering amount
- $203.1K
- Amount sold
- $203.1K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3.8MraisedOct 2021 · 7 investors · BiotechnologyRule 506(b)
▶$3.8MraisedOct 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES WILKIEExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $3.8M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Lowell Therapeutics raised?
- Lowell Therapeutics has disclosed $5M raised across 3 rounds.
- Where is Lowell Therapeutics headquartered?
- Lowell Therapeutics is headquartered in Lowell, US.